Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 3/2017

07.11.2016 | Original Article

The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles

verfasst von: N. Purandare, G. Emerson, C. Kirkham, C. Harrity, D. Walsh, E. Mocanu

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Ovarian stimulation is an essential part of assisted reproduction treatments. Research on whether the duration of stimulation alters the success in assisted reproduction has not been conclusive.

Aim

The purpose of the study was to establish whether the duration of ovarian stimulation alters the success in assisted reproduction treatments.

Methods

All fresh (non-donor) stimulation cycles performed in an academic tertiary referral ART centre over a period of 18 years, between 1st January 1997 and 31st December 2014, were identified. Data were prospectively and electronically collected. IVF and ICSI cycles were analysed independently. Each category was then subdivided into assisted reproduction cycles where the antagonist, long (down regulation) and flare protocol were used. Clinical pregnancy was the main outcome measured. A total of 10,478 stimulation cycles (6011 fresh IVF and 4467 fresh ICSI) reaching egg collection were included.

Results

We showed no significant difference in CP rates in IVF cycles for the long (p = 0.082), antagonist (p = 0.217) or flare (p = 0.741) protocol cycles or in ICSI cycles with the long (p = 0.223), antagonist (p = 0.766) or the flare (p = 0.690) protocol with regards the duration of stimulation.

Conclusion

The duration of stimulation does not alter the CP rate in ICSI or IVF cycles using the long, antagonist or flare stimulation protocol.
Literatur
1.
Zurück zum Zitat Ryan A, Wang S, Alvero R et al (2014) Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome. J Assist Reprod Genet 31(7):837–842CrossRefPubMedPubMedCentral Ryan A, Wang S, Alvero R et al (2014) Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome. J Assist Reprod Genet 31(7):837–842CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Bonilla-Musoles F, Castillo JC, Caballero O et al (2012) Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol 39(1):13–18PubMed Bonilla-Musoles F, Castillo JC, Caballero O et al (2012) Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure. Clin Exp Obstet Gynecol 39(1):13–18PubMed
3.
Zurück zum Zitat Martin JS, Nisker JA, Tummon IS et al (1996) Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril 65:1238–1240CrossRefPubMed Martin JS, Nisker JA, Tummon IS et al (1996) Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril 65:1238–1240CrossRefPubMed
4.
Zurück zum Zitat Hock DL, Louie H, Shelden RM et al (1998) The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome. J Assist Reprod Genet 15:427–430CrossRefPubMedPubMedCentral Hock DL, Louie H, Shelden RM et al (1998) The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome. J Assist Reprod Genet 15:427–430CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Maheshwari A, Stofberg L, Bhattacharya S (2007) Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 13:433–444CrossRefPubMed Maheshwari A, Stofberg L, Bhattacharya S (2007) Effect of overweight and obesity on assisted reproductive technology—a systematic review. Hum Reprod Update. 13:433–444CrossRefPubMed
6.
Zurück zum Zitat Baker VL, Luke B, Brown MB et al (2010) Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the society for assisted reproductive technology clinic outcomes reporting system. Fertil Steril 94:1410–1416CrossRefPubMed Baker VL, Luke B, Brown MB et al (2010) Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the society for assisted reproductive technology clinic outcomes reporting system. Fertil Steril 94:1410–1416CrossRefPubMed
7.
Zurück zum Zitat Huang JYJ, Rosenwaks Z (2012) In vitro fertilisation treatment and factors affecting success. Best Pract Res Clin Obstet Gynaecol 26:777–788CrossRefPubMed Huang JYJ, Rosenwaks Z (2012) In vitro fertilisation treatment and factors affecting success. Best Pract Res Clin Obstet Gynaecol 26:777–788CrossRefPubMed
9.
Zurück zum Zitat Martin JR, Mahutte NG, Arici A et al (2006) Impact of duration and dose of gonadotrophins on IVF outcomes. Reprod Biomed Online. 13:645–650CrossRefPubMed Martin JR, Mahutte NG, Arici A et al (2006) Impact of duration and dose of gonadotrophins on IVF outcomes. Reprod Biomed Online. 13:645–650CrossRefPubMed
10.
Zurück zum Zitat Chen SL, Sun L, Kong LH, Li L et al (2007) Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi. 42:526–529PubMed Chen SL, Sun L, Kong LH, Li L et al (2007) Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization. Zhonghua Fu Chan Ke Za Zhi. 42:526–529PubMed
11.
Zurück zum Zitat Youssef MA, Abdelmoty HI, Ahmed MA et al (2015) GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: systematic review and meta-analysis. J Adv Res. 6(3):341–349CrossRefPubMedPubMedCentral Youssef MA, Abdelmoty HI, Ahmed MA et al (2015) GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: systematic review and meta-analysis. J Adv Res. 6(3):341–349CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Samara N, Reis D, Danielli Miller N et al (2015) What are the best predictors for successful GnRH antagonist protocol in vitro fertilization (IVF) treatment? Gynecol Endocrinol 29:1–3 Samara N, Reis D, Danielli Miller N et al (2015) What are the best predictors for successful GnRH antagonist protocol in vitro fertilization (IVF) treatment? Gynecol Endocrinol 29:1–3
13.
Zurück zum Zitat Mardešič T, Mannaerts B, Abuzeid M et al (2014) Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective analysis of the Engage trial. Reprod Biomed Online. 28(4):462–468CrossRefPubMed Mardešič T, Mannaerts B, Abuzeid M et al (2014) Short follicular phase of stimulation following corifollitropin alfa or daily recombinant FSH treatment does not compromise clinical outcome: a retrospective analysis of the Engage trial. Reprod Biomed Online. 28(4):462–468CrossRefPubMed
Metadaten
Titel
The duration of gonadotropin stimulation does not alter the clinical pregnancy rate in IVF or ICSI cycles
verfasst von
N. Purandare
G. Emerson
C. Kirkham
C. Harrity
D. Walsh
E. Mocanu
Publikationsdatum
07.11.2016
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 3/2017
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-016-1526-3

Weitere Artikel der Ausgabe 3/2017

Irish Journal of Medical Science (1971 -) 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.